Notably, p‐TFCP2L1 and CDK1 were highly expressed in tumor tissues of BC patients with aggressive clinicopathological features, and this expression was associated with significantly shorter cancer‐specific survival (Fig 3D). The gene discussed is TFCP2L1; the disease is neoplasm.